NCT05373498

Brief Summary

Children with congenital heart defects are far more likely to suffer a cardiovascular arrest and be in the need of cardiopulmonary resuscitation than healthy children or those with diseases of other organ systems, especially after cardiothoracic surgery. Due to a lack of data, the exact number of resuscitations in this patient cohort, as well as the morbidity and mortality, is unknown. This study aims to register all cardiovascular arrests in pediatric patients with congenital heart disease and study the mortality and morbidity with a special focus on the neurodevelopmental outcome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
81mo left

Started Aug 2022

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Aug 2022Dec 2032

First Submitted

Initial submission to the registry

March 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 13, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 18, 2022

Completed
8.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Last Updated

January 16, 2025

Status Verified

January 1, 2025

Enrollment Period

8.4 years

First QC Date

March 25, 2022

Last Update Submit

January 15, 2025

Conditions

Keywords

pediatric resuscitation outcomecongenital heart diseaseneurodevelopmental outcome

Outcome Measures

Primary Outcomes (1)

  • survival to hospital discharge

    until the date of discharge or death from any cause, whichever came first, assessed up to 2 months

Secondary Outcomes (2)

  • Number of return of spontaneous circulation

    until the date of discharge or spontaneous circulation from any cause, whichever came first, assessed up to 2 months

  • Rate of morbidity

    until 2 years

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children: 0 - 18 years

You may qualify if:

  • congenital heart defects, congenital heart arrhythmia, familial cardiomyopathies, inflammatory heart diseases
  • pediatric resuscitation (chest compressions ≥2min) in hospital or on arrival in hospital
  • age \<18 years
  • informed consent of the parents or legal representative

You may not qualify if:

  • absence or withdrawal of informed consent of the parents or legal representative
  • do-not-resuscitate-order (DNR)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Herzzentrum Leipzig

Leipzig, Saxony, 04289, Germany

RECRUITING

Deutsches Herzzentrum Berlin

Berlin, 13353, Germany

NOT YET RECRUITING

Universitätsklinikum Bonn (AöR)

Bonn, 53127, Germany

NOT YET RECRUITING

Related Publications (1)

  • Markel F, Kramer P, Anand J, Heimberg E, Herbsleb V, Amann V, Herberg U, von Borell du Vernay F, Seidemann K, Liem L, Michaelis A, Schmitt K, Weidenbach M. Paediatric Resuscitation Outcome in Children with Heart Disease (ProCHD): protocol of a Germany-wide multicentre, prospective open registry. BMJ Open. 2026 Jan 8;16(1):e107163. doi: 10.1136/bmjopen-2025-107163.

MeSH Terms

Conditions

Heart ArrestHeart Defects, Congenital

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
24 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2022

First Posted

May 13, 2022

Study Start

August 18, 2022

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2032

Last Updated

January 16, 2025

Record last verified: 2025-01

Locations